Therefore, one can envision that AFP-based vaccines might be helpful in preventing or significantly delaying the onset of HCC in this population, particularly at-risk patients who have cirrhosis and are enrolled in a radiographic screening program. The gene discussed is AFP; the disease is Cirrhosis.